Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Drugs Public Price List


Lebanon National Drugs Database

 
Drugs Prices According to the Exchange Rate Issued on 5/2/2024
  • Drugs Public Price List according to decision no. 119/1 published in the Official Gazette of 30/01/2020
    
Date Exchange Rate Drugs Public Price
13/6/2024 89,500 LBP Drugs Public Price List
27/5/2024 89,500 LBP Drugs Public Price List
14/5/2024 89,500 LBP Drugs Public Price List
17/4/2024 89,500 LBP Drugs Public Price List
21/3/2024 89,500 LBP Drugs Public Price List
20/3/2024 89,500 LBP Drugs Public Price List
7/3/2024 89,500 LBP Drugs Public Price List
12/2/2024 90,000 LBP Drugs Public Price List
5/2/2024 90,000 LBP Drugs Public Price List
  • Non Subsidized Drugs List issued on 1/2/2023 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds." (You can check the updated prices in the Drugs Public Price List)
Date Non Subsidized Drugs
13/6/2024 Non subsidized Drugs List
14/5/2024 Non subsidized Drugs List
17/4/2024 Non subsidized Drugs List
21/3/2024 Non subsidized Drugs List
20/3/2024 Non subsidized Drugs List
7/3/2024 Non subsidized Drugs List
12/2/2024 Non subsidized Drugs List
5/2/2024 Non subsidized Drugs List
  • The list of medicines covered by Resolution 945/1 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds."
 
Date Exchange Rate Medicines covered by Resolution 945/1
13/6/2024 89,500 LBP List of medicines covered by Resolution 945/1
27/5/2024 89,500 LBP List of medicines covered by Resolution 945/1
14/5/2024 89,500 LBP List of medicines covered by Resolution 945/1
17/4/2024 89,500 LBP List of medicines covered by Resolution 945/1
21/3/2024 89,500 LBP List of medicines covered by Resolution 945/1
20/3/2024 89,500 LBP List of medicines covered by Resolution 945/1
7/3/2024 89,500 LBP List of medicines covered by Resolution 945/1
12/2/2024 90,000 LBP List of medicines covered by Resolution 945/1
5/2/2024 90,000 LBP List of medicines covered by Resolution 945/1
 
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E1) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E2) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
 
Drugs Prices According to the Exchange Rate Issued on 10/1/2024
  • Drugs Public Price List according to decision no. 119/1 published in the Official Gazette of 30/01/2020
    
Date Exchange Rate Drugs Public Price
10/1/2024 90,000 LBP Drugs Public Price List
  • Non Subsidized Drugs List issued on 1/2/2023 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds." (You can check the updated prices in the Drugs Public Price List)
Date Non Subsidized Drugs
15/1/2024 Addendum: Non subsidized Drugs List
10/1/2024 Non subsidized Drugs List
  • The list of medicines covered by Resolution 945/1 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds."
 
Date Exchange Rate Medicines covered by Resolution 945/1
10/1/2024 90,000 LBP List of medicines covered by Resolution 945/1
 
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E1) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E2) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
 

Drugs Prices Reduction
Lists of Drugs Prices Reduced From 2015 until 2019
 
    ...
    106
    ...
ATC Name B/G Ingredients Dosage Form Price
J06BB04 IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB BioHuman Hepatitis B immunoglobulin (human) - 100UI/ml 100UI/ml Injectable solution 6,853,730 L.L
J06BB04 IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB BioHuman Hepatitis B immunoglobulin (human) - 500UI/5ml 500UI/5ml Injectable solution 11,100,643 L.L
J06BB05 RABISHIELD-100 (RABIES HUMAN MONOCLONAL ANTIBODY rDNA) BioHuman Rabies, Human IgG1 Monoclonal Antibody - 100IU/2.5ml 100IU/2.5ml 8,455,824 L.L
J06BD01 SYNAGIS BioTech Palivizumab - 100mg/ml 100mg/ml Injectable solution 1,250,230 L.L
J06BD01 SYNAGIS BioTech Palivizumab - 50mg/0.5ml 50mg/0.5ml Injectable solution 742,477 L.L
J07AH MENFIVE G Meningococcal (serogroups A, C, Y, W, X) Polysaccharide conjugate vaccine - Injectable freeze dried powder + diluent 3,527,587 L.L
J07AH08 MENACTRA MENINGOCOCCAL POLYSACCHARIDE DIPHTERIA TOXOID CONJUGATE VACCINE B Meningococcal Polysaccharides (serogroups A, C, Y and W-135) - 4mcg/0.5ml each, Diphteria Toxoid Protein - 48mcg/0.5ml Injectable solution 6,144,048 L.L
J07AH08 NIMENRIX B Polysaccharide of Neisseria meningitidis (serogroups A, C, Y and W-135) conjugated - 5mcg/0.5ml, Tetanus toxoid carrier protein - 44mcg/0.5ml Injectable lyophilised powder for solution+diluent 4,483,059 L.L
J07AH08 MENQUADFI G Meningococcal (serogroups A, C, W and Y) conjugate vaccine - Injectable solution 4,859,334 L.L
J07AJ51 BOOSTRIX B Diphteria toxoid purified - ?2.5Lf/0.5ml, Tetanus toxoid purified - ?5Lf/0.5ml, Bordetella Pertussis Antigens: toxoid - 8mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 8mcg/0.5ml, Pertactine - 2.5mcg Al3+/0.5ml, Aluminium hydroxide - 0.3mg Al3+/0.5ml, Aluminium Phosphate - 0.2mg/0.5ml Injectable suspension 1,394,909 L.L
J07AL01 PNEUMOVAX 23 B Polysaccharides from each of 23 capsular types of Streptococcus pneumoniae - 25mcgx23serotypes/0.5ml Injectable solution 2,409,510 L.L
J07AL02 PREVENAR 13 B Polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 23F (2.2mcg)Polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate (0.125mg aluminium) - Injectable suspension 6,863,004 L.L
J07AL02 SYNFLORIX B Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg Injectable suspension 4,675,228 L.L
J07AL02 PNEUMOSIL (10-VALENT) G Pneumococcal polysaccharide conjugate vaccine (adsorbed) - Injectable suspension 3,386,483 L.L
J07AL02 PREVENAR 20 B Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F,8, 9V,10A, 11A, 12F, 14, 15B, 18C, 19A, 19F,22F, 23F, 33F (2.2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein (approximately 51mcg) adsorbed on aluminium phosphate (0.125mg aluminium) - Injectable suspension 7,415,107 L.L
J07AL02 VAXNEUVANCE B Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 22F, 23F,33F (2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg) Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate adjuvant - Injectable suspension 6,988,413 L.L
J07AP03 TYPHIM VI B Salmonella typhi polysaccharides - 0.025mg/0.5ml 0.025mg/0.5ml Injectable solution 1,118,077 L.L
J07AP03 TYPHIBEV TYPHOID CONJUGATED VACCINE (MONOVALENT) B Salmonella typhi polysaccharides Vi purified - 25mcg of Vi-PS2/0.5ml Injectable suspension 4,020,777 L.L
J07AX URO-VAXOM B Lyophilized bacterial lysates of E-Coli - 6mg 6mg Capsule 2,689,029 L.L
J07AX BRONCHO-VAXOM CHILDREN B Lyophilized bacterial lysates of Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis - 3.5mg Capsule 1,988,887 L.L
J07AX BRONCHO-VAXOM ADULTS B Lyophilized bacterial lysates of Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis - 7mg Capsule 2,827,445 L.L
J07BB01 INFLUVAC TETRA B Influenza virus surface antigens inactivated (haemagglutinin and neuraminidase) - 15mcg/4strains/0.5ml Injectable suspension 970,254 L.L
J07BB01 VAXIGRIPTETRA, VACCIN GRIPPAL QUADRIVALENT (INACTIVE A VIRION FRAGMENTE) B Influenza vaccine virus (inactivated, split) - 15mcg/4strains/0.5ml Injectable suspension 970,254 L.L
J07BB02 INFLUVAC B Grippal virus surface antigen 3strains - 15mcgx3strains/0.5ml Injectable suspension 573,821 L.L
J07BC01 ENGERIX-B 20 B Hepatitis B, purified antigen - 20mcg/ml 20mcg/ml Injectable suspension 1,652,926 L.L
J07BC01 ENGERIX-B 10 B Hepatitis B, surface antigen - 10mcg/0.5ml 10mcg/0.5ml Injectable suspension 1,042,822 L.L
J07BC01 HEPATITIS-B VACCINE (r DNA) PAEDIATRIC G Hepatitis B, purified surface antigen adsorbed on aluminium hydroxide (Al+++) (0.25mg to 0.40mg) - 10mcg/0.5ml 10mcg/0.5ml Injectable suspension 323,866 L.L
J07BC02 HAVRIX '1440' B Hepatitis A, inactivated, whole virus - 1,440 ELISA units/ml 1,440 ELISA units/ml Injectable suspension 2,215,996 L.L
J07BC02 HAVRIX JUNIOR 720 B Hepatitis A, inactivated, whole virus - 720 ELISA units/0.5ml 720 ELISA units/0.5ml Injectable suspension 1,491,665 L.L
J07BC02 AVAXIM PEDIATRIQUE (vaccin inactivé de l'hépatite A adsorbé) B Hepatitis A, inactivated, whole virus - 80 antigen units/0.5ml 80 antigen units/0.5ml Injectable suspension 1,531,980 L.L
    ...
    106
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2024